58 related articles for article (PubMed ID: 10585717)
1. Mapping signal transduction pathways by phage display.
Zozulya S; Lioubin M; Hill RJ; Abram C; Gishizky ML
Nat Biotechnol; 1999 Dec; 17(12):1193-8. PubMed ID: 10585717
[TBL] [Abstract][Full Text] [Related]
2. MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.
Higuchi T; Orita T; Katsuya K; Yamasaki Y; Akiyama K; Li H; Yamamoto T; Saito Y; Nakamura M
Mol Cell Biol; 2004 Sep; 24(17):7456-68. PubMed ID: 15314156
[TBL] [Abstract][Full Text] [Related]
3. Direct selection of EGF mutants displayed on filamentous phage using cells overexpressing EGF receptor.
Souriau C; Gracy J; Chiche L; Weill M
Biol Chem; 1999 Apr; 380(4):451-8. PubMed ID: 10355631
[TBL] [Abstract][Full Text] [Related]
4. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
5. Identification of epidermal growth factor receptor- Grb2-associated binder-1-SHP-2 complex formation and its functional loss during neoplastic cell progression.
Kameda H; Risinger JI; Han BB; Baek SJ; Barrett JC; Glasgow WC; Eling TE
Cell Growth Differ; 2001 Jun; 12(6):307-18. PubMed ID: 11432805
[TBL] [Abstract][Full Text] [Related]
6. Adaptor signalling proteins Grb2 and Grb7 are recruited by human G6f, a novel member of the immunoglobulin superfamily encoded in the MHC.
De Vet EC; Aguado B; Campbell RD
Biochem J; 2003 Oct; 375(Pt 1):207-13. PubMed ID: 12852788
[TBL] [Abstract][Full Text] [Related]
7. Identification of signalling components in tyrosine kinase cascades using phosphopeptide affinity chromatography.
Duménil G; Rubini M; Dubois G; Baserga R; Fellous M; Pellegrini S
Biochem Biophys Res Commun; 1997 May; 234(3):748-53. PubMed ID: 9175787
[TBL] [Abstract][Full Text] [Related]
8. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
9. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
11. Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells.
Rubio I; Rennert K; Wittig U; Beer K; Dürst M; Stang SL; Stone J; Wetzker R
Biochem J; 2006 Sep; 398(2):243-56. PubMed ID: 16709153
[TBL] [Abstract][Full Text] [Related]
12. Sprouty2 binds Grb2 at two different proline-rich regions, and the mechanism of ERK inhibition is independent of this interaction.
Martínez N; García-Domínguez CA; Domingo B; Oliva JL; Zarich N; Sánchez A; Gutiérrez-Eisman S; Llopis J; Rojas JM
Cell Signal; 2007 Nov; 19(11):2277-85. PubMed ID: 17689925
[TBL] [Abstract][Full Text] [Related]
13. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
Hyland S; Beerli RR; Barbas CF; Hynes NE; Wels W
Oncogene; 2003 Mar; 22(10):1557-67. PubMed ID: 12629519
[TBL] [Abstract][Full Text] [Related]
14. Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.
Watanabe T; Shinohara N; Moriya K; Sazawa A; Kobayashi Y; Ogiso Y; Takiguchi M; Yasuda J; Koyanagi T; Kuzumaki N; Hashimoto A
IUBMB Life; 2000 Apr; 49(4):317-20. PubMed ID: 10995035
[TBL] [Abstract][Full Text] [Related]
15. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
Zhou D; Chen B; Ye JJ; Chen S
Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
[TBL] [Abstract][Full Text] [Related]
16. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
Boerner JL; Danielsen AJ; Lovejoy CA; Wang Z; Juneja SC; Faupel-Badger JM; Darce JR; Maihle NJ
Oncogene; 2003 Oct; 22(43):6679-89. PubMed ID: 14555981
[TBL] [Abstract][Full Text] [Related]
17. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
Hanafusa H; Torii S; Yasunaga T; Nishida E
Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
[TBL] [Abstract][Full Text] [Related]
18. Sprouty: how does the branch manager work?
Guy GR; Wong ES; Yusoff P; Chandramouli S; Lo TL; Lim J; Fong CW
J Cell Sci; 2003 Aug; 116(Pt 15):3061-8. PubMed ID: 12829736
[TBL] [Abstract][Full Text] [Related]
19. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
[TBL] [Abstract][Full Text] [Related]
20. In vivo selection of protease cleavage sites from retrovirus display libraries.
Buchholz CJ; Peng KW; Morling FJ; Zhang J; Cosset FL; Russell SJ
Nat Biotechnol; 1998 Oct; 16(10):951-4. PubMed ID: 9788352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
